Microbial Fermentation Manufacturing: Advances through single-use technologies

daniel-tischler

Daniel Tischler

March 17, 2023

Table of contents

Show

Microbial fermentation is a powerful, flexible microbiology process used to generate microbial cells or biomass such as proteins and enzymes for the production of vaccines and therapeutics.

Consequently, fermentation technology is a rapidly growing field within the biopharmaceutical industry. However, growth and ongoing development are accompanied by constant challenges, including 

  • product quality and
  • potential of toxic by-products
  • lack of scalability
  • cost-effective solutions
  • timelines
  • capacities
  • capabilities

Many of these challenges in fermentation manufacturing can be solved by replacing traditional systems with single-use technologies. A change to more agile systems supports manufacturers and CDMOs, if manufacturing is outsourced, so such a move pays off twice. 

Production of pharmaceutical compounds through microbial fermentation

As a multi-disciplinary methodology, fermentation technology offers the option to recover and purify specific desired APIs out of the molecular repertoire. The process involves the use of microorganisms that can be harvested in much bigger quantities and at higher levels of concentration than the results of mammalian cell expression.

There is a clear preference from chemical synthesis shifting to microbial fermentation, but there are still a number of hurdles to be taken. One of the most important ones is to find integrative solutions that are flexible and allow for scale-up, still keeping product quality high.

However, apart from an existing technology gap and the need for scalability, there are other issues that need to be addressed in pharmaceutical fermentation. These include, most notably, timelines, costs, and expertise. 

fermentation-pharmaceutical-industry

Application of single-use technology in microbial fermentation manufacturing

So far, the common approach in fermentation processes was to use stainless-steel bioreactors for microbial production. And even though single-use systems are gaining traction, there is still a lot of room for optimization, both in terms of process development and manufacturing process.

As one of the key topics in many biotech processes, scalability needs to be considered from the initial stages of process development. Manufacturers have to be able to achieve immediate scale-up once the product has been given the green light for production on an industrial scale. However, not only does large-scale production call for additional equipment and different infrastructures. The entire process requires careful monitoring to ensure stability as well as product quality, process control and safety.

This is where single-use technologies come in: The modular systems provide efficiency, flexibility, scalability and reliability along the fluid management and cold chain logistics in upstream and downstream processing.

Navigating 5 Overlooked Challenges in Biopharmaceutical Fermentation

Guide about Handling Liquids in Biopharmaceutical Fermentation | Scalability in Microbial Mammalian Fungal Fermentation | Replacing Spray Drying and Lyophilization with Bulk Plate Freezing | Speed of Handling Large Volumes in Fermentation | Bag Breakages in fermentation cold chain logistics

How are single-use technologies contributing to drive the microbial fermentation industry?

While cost and time savings could be among the most cited advantages of single-use technologies in biotechnology, they are only representative of one aspect. Far more importantly, they drive agility, flexibility, and speed to market while also reducing the risk of cross-contamination and improving sustainability in contrast to stainless steel. However, there are also differences within single-use technologies.

Below are some of the most important benefits of single-use technologies employed in biomanufacturing, with a focus in microbial fermentation:

  • Single-use technologies create good conditions for fast freezing of large volumes - at least the solutions from Single Use Support do
  • More cost-effective processes thanks to an increased flexibility in responding to on-demand production
  • Accelerated speed to market by removing the need to clean, sterilize and recycle components - again, at least solutions from Single Use Support do so
  • Improved sterility thanks to automated processes and improved controls
  • Reduced need for cleaning and minimized process downtime thanks to pre-assembled and sterilized fluid flow paths
Single-use solutions for Microbial Production

What matters in microbial fermentation manufacturing?

With the biologics market expected to reach a volume of USD 450 billion by 2025, the time-to-market rate is increasing continuously, but apart from time there are important factors. Below we have provided some answers and solutions for the most pressing topics in microbial fermentation:

  • Speed: Fast processing of the ferments is important to maintain product quality. In the case of downtime or transport, the liquids are advised to be frozen quickly. This is to avoid affecting the viability of the product as in other freezing methods, e.g. spray drying.
  • Quality: Product activity is kept high by freezing the substances quickly and homogeneously. Plate-based freezing in single-use bags is the best way to do so. 
  • Sustainability: Manufacturing can become more environmentally sustainable by employing processes that save material, time and energy consumption. Manufacturing based on single-use technologies, unlike stainless-steel, is more efficient and consumes less energy due to the elimination of cleaning.
  • Safety: This can be achieved through a higher level of automation, a lower risk of human error or contamination, and improved protection offered by single-use components. 
  • Compliance: This can be ensured by using cGMP-compliant single-use components that are, notably, more efficient, cost-effective, and scalable than stainless-steel tanks.

Single-use consumables for microbial fermentation

The clear trend towards single-use technologies brings with it an increasing range of components and products. Single Use Support’s solutions are available for or adaptable to different processes, respectively process and logistics steps from upstream to downstream, freezing and fill/finish, storage and shipping.

IRIS bioprocess containers can be tailored to different needs to store, ship and freeze anything from cell culture samples to drug substances on a large scale.

RoSS shells protect single-use bags safely. The robust solution for storage and shipping during cold chain management protects any bioprocess container to reduce product loss towards 0%.

IRIS single-use assemblies ensure a GMP-, FDA- and ISO-compliant sterilized fluid flow and aseptic handling of pharmaceutical products. Availability and compatibility prevents downtime thanks to an uninterrupted supply chain.

RoSS.SHIP shipping containers are ideal for the storage and monitored shipping of bulk drug substances by maintaining the cold chain for almost and offering integrated Smart Tracking.

In addition to single-use consumables, there are end-to-end processes based on single-use technologies that help drive efficiency and safety while reducing product loss and human error. Since they are primarily based on single-use technologies, those automated processes allow for the greatest process flexibility while also complying with important cGMP/GMP criteria.

Single Use Support’s flexible end-to-end process solutions for advanced fluid management and freeze-thaw logistics facilitate aseptic automated aliquotation into single-use bioprocess containers and controlled freezing to -80 °C. 200 liters or more can be filled and frozen in less than 8 hours. Read more: Fast filling and freezing large volumes for fermentation

The vendor-agnostic and modular systems simplify the handling of process intermediates on a large scale. They can be used for different areas of applications like plasmid DNA, viral vectors, antibody-drug conjugates and vaccine manufacturing. 

Single use bag protection for drug substances in bulk stream with RoSS shell by Single Use Support

RoSS® Shell | Protecting single-use bags

The safest transport solution for all available single-use bioprocess containers. Robust. Scalable. Single-use bag independent.

Single Use Support shipper

RoSS.SHIP | Ship, Track & Trace

RoSS.SHIP secures the cold chain shipping and storing of bulk drug substance for almost one week. Highly robust, stackable, coolable and compact – Fort Knox for high-quality substances!

IRIS Bag

IRIS Single-Use Bioprocess Container

Innovative. Robust. Individual. Single-Use. Make sure your supply chain is uninterrupted. Get your IRIS 2D single-use bioprocess container from Single Use Support in any size with the fastest possible delivery times. Store and ship anything from cell culture samples to large drug substance volumes reliably and on time.

IRIS Single-Use Assmeblies_Production Kufstein-29

IRIS Manifold | Single-Use Assemblies

As an expert in single-use solutions, we have made it our goal to deliver vendor agnostic single-use assemblies manufactured at highest quality standards in ISO 7 cleanrooms and sterilized within shortest lead times. Prevent downtime and ensure an uninterrupted supply chain in compliance with GMP and regulatory requirements with our single-use manifold assemblies using silicone tubing and connectors of your choice.

Automated end-to-end processes based on single-use technologies

In addition to single-use consumables, there are end-to-end processes based on single-use technologies that help drive efficiency and safety while reducing product loss and human error. Since they are primarily based on single-use technologies, those automated processes allow for the greatest process flexibility while also complying with important cGMP/GMP criteria.

Single Use Support’s flexible end-to-end process solutions for advanced fluid management and freeze-thaw logistics facilitate aseptic automated aliquotation into single-use bioprocess containers and controlled freezing to -80 °C. 200 liters or more can be filled and frozen in less than 8 hours. Read more: Fast filling and freezing large volumes for fermentation

The vendor-agnostic and modular systems simplify the handling of process intermediates on a large scale. They can be used for different areas of applications like plasmid DNA, viral vectors, antibody-drug conjugates and vaccine manufacturing. 

FAQs about microbial fermentation manufacturing

Why are E. coli bacteria one of the preferred microbes used in fermentation processes?

Escherichia coli is one of the preferred microbes for cell factories used in the fermentation process because of their short fermentation times and high cell density. In addition, E. coli stands out thanks to their simple and rapid strain development. All of these are highly desirable characteristics in microorganisms used for the production of biopharmaceuticals and other pharmaceutical products.

What does microbial fermentation entail?

Fermentation is a biochemical process that occurs within cells. During fermentation, microorganisms metabolize organic compounds to produce energy and generate various end products. Strain selection and optimization, media and process development are - besides the ability to scale-up - some of the key elements of microbial fermentation. Read more about the differences between microbial fermentation and mammalian cell culture

Why has microbial fermentation become so popular?

This process results in larger volumes and higher concentrations than is possible with mammalian cell expression. It involves the use of bacteria like E. coli, yeast - for example Pichia pastoris - and other microorganisms to generate APIs like acids, recombinant proteins and monoclonal antibodies. 

What exactly are APIs?

APIs are Active Pharmaceutical Ingredients used in vaccines and medical therapies.  The molecules that are of primary interest to the pharmaceutical industry can be cultured and grown via microbial fermentation. They include small molecules such as short peptides, larger molecules like proteins and nucleic acids (DNA, RNA) and macromolecules such as lipids and carbohydrate polymers. All of them could serve as a drug’s Active Pharmaceutical Ingredient (API). (Source: manufacturingchemist.com)

Further readings about microbial fermentation manufacturing

Bioprocessing Downstream

Cold chain handling for fermentation: Single-use solutions to lower costs

As expert for cold chain handling in bioprocessing, Single Use Support is providing solutions to meet challenges for safe storing and shipping associated with right freezing and thawing methods and temperature control for long-term storage. Their development approach leads to innovative systems that enable manufacturers to replace manual processes with fully automated end-to-end processes that not only push efficiency but also increase output.

RoSS.pFTU XL_Product Detail-1

Filling & Freezing large volumes for fermentation in less than 8 hours

The filling and freezing of large volumes for fermentation is an essential part during different production steps in upstream and downstream processing.  In the following, we will explain why it is important to act fast and how an optimization of the process can be achieved. 

Challenges in microbial fermentation manufacturing

Challenges in microbial fermentation manufacturing

Microbial fermentation manufacturing is an effective method for the production of APIs, bioconjugates and smaller biologicals that play an important role in biotechnology and the production of biopharmaceuticals. Manufacturers face different challenges during microbial fermentation. Explore the 7 biggest challenges, followed by the introduction of new solutions.

Reducing human error & product loss in pharmaceutical fermentation

Reducing product loss & human error in pharmaceutical fermentation

Pharmaceutical manufacturing processes, including pharmaceutical fermentation, are still prone to human error and product loss. The challenges can be overcome by moving to automated processes that eliminate the need for slow and error-prone manual handling. Adopting automated end-to-end solutions based on single-use technologies minimizes, if not eliminates, human error and product loss.

Microbial cGMP production: complete guide & manufacturer's overview

Microbial cGMP production: complete guide & manufacturer's overview

Microbial fermentation is a hot topic not only in the biopharma industry. In this article, you will find a brief overview of microbial fermentation manufacturing before we discover different CDMOs offering microbial cGMP production.

daniel-tischler

Daniel Tischler

Director Integrated Solutions

Daniel Tischler is Director Integrated Solutions with experience in sales & business development, product line management, application engineering at Single Use Support.

Proximity to mechatronic systems and to customers were two constants for Daniel Tischler. At Single Use Support he started as a project manager. Later he provided customers technical insights as sales application engineer. Daniel was Head of Product Line Management working on new innovations for customers in the biopharmaceutical industry, before he has started as Director of Commercial Operations.

Daniel has gained 10+ years of expertise in design engineering and project management before he joined Single Use Support.

More from Daniel Tischler

Monoclonal Antibodies

The 3 Most Overlooked Costs in Monoclonal Antibody Production

In the quest for efficient monoclonal antibody manufacturing, it's imperative to shed light on costs that are frequently underestimated. These costs can stem from various sources, including process development, high prices associated with biotherapeutics, and the evolving landscape of production technologies.

daniel-tischler

Daniel Tischler

February 6, 2024

Vaccines

13 vaccine manufacturing companies you need to know

The vaccine market is shaped by numerous companies, from smaller newcomers to international concerns. In this article, we will uncover 13 vaccine manufacturing companies you ought to know.

daniel-tischler

Daniel Tischler

December 4, 2023

Read more about Fermentation

Freeze & Thaw

Dry to Die: How Spray Drying can be Replaced by Freezing in the Production of Bulk Intermediates

Spray drying often leads to product losses of mAbs or vaccines of more than 30%. Plate-based freezing and thawing solutions enable controlled handling of bulk intermediates safely in a vendor-independent, modular and scalable fluid and cold chain management process. 

daniel-tischler

Daniel Tischler

April 12, 2023

Fermentation

Challenges in microbial fermentation manufacturing

Microbial fermentation manufacturing is an effective method for the production of APIs, bioconjugates and smaller biologicals that play an important role in biotechnology and the production of biopharmaceuticals. Manufacturers face different challenges during microbial fermentation. Explore the 7 biggest challenges, followed by the introduction of new solutions.

daniel-tischler

Daniel Tischler

March 16, 2023

Fermentation

Filling & Freezing large volumes for fermentation in less than 8 hours

The filling and freezing of large volumes for fermentation is an essential part during different production steps in upstream and downstream processing.  In the following, we will explain why it is important to act fast and how an optimization of the process can be achieved. 

daniel-tischler

Daniel Tischler

March 16, 2023

Fermentation

Cold chain handling for fermentation: Single-use solutions to lower costs

As expert for cold chain handling in bioprocessing, Single Use Support is providing solutions to meet challenges for safe storing and shipping associated with right freezing and thawing methods and temperature control for long-term storage. Their development approach leads to innovative systems that enable manufacturers to replace manual processes with fully automated end-to-end processes that not only push efficiency but also increase output.

Alexander Fuchs | Single Use Support

Alexander Fuchs

March 14, 2023